Lancet Hematology Commission on Anemia

Project Details

Anaemia remains a significant public health problem worldwide, particularly in women of reproductive age, a population in which the prevalence and severity of the the disease is high, with flow on consequences for fetal development and child health creating a multiplier effect to the burden of disease. Reducing the prevalence of anaemia by 50% worldwide by 2030 is an ambitious target outlined in both the Sustainable Development Goals and the World Heath Organisation's Global Nutrition Targets. However, despite the availability of evidence-based interventions for the prevention and treatment of anaemia, no country is currently on track to meet these targets, with rates on anaemia increasing in some countries.

The Lancet Haematology Commission is an international collaboration seeking to catalyse progress towards addressing the prevalence of anaemia worldwide by consolidating the current state of knowledge on all aspects of anaemia, from pathophysiology and epidemiology through to public health interventions and the science underlying their implementation and adoption. Along with collaborators at the Queensland University of Technology and the University of Adelaide, the Economics of Global Health and Infectious Diseases Unit is contributing to this program by exploring innovative approaches to goal setting, which are guided by health economic modelling principles, to ensure future targets for controlling anaemia are ambitious and achievable for all countries.

Project Duration

2023–2025

Researchers

• A/Prof Natalie Carvalho (Project Lead)
• Dr Tori Oliver
• Cyan Wang
• Dr Clare Glover-Wright

Funding

Bill & Melinda Gates Foundation